• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孵育后的丙烯酸人工晶状体中缓释塞来昔布抑制后发性白内障模型中外生性后囊混浊中晶状体上皮细胞的生长。

Sustained-release celecoxib from incubated acrylic intraocular lenses suppresses lens epithelial cell growth in an ex vivo model of posterior capsule opacity.

机构信息

Department of Clinical Sciences, North Carolina State University, Raleigh, NC 27607, USA.

出版信息

J Ocul Pharmacol Ther. 2012 Aug;28(4):359-68. doi: 10.1089/jop.2011.0196. Epub 2012 Feb 28.

DOI:10.1089/jop.2011.0196
PMID:22372691
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3406318/
Abstract

PURPOSE

To determine whether celecoxib (CXB) can be released from incubated intraocular lenses (IOLs) sufficiently to inhibit lens epithelial cell (LEC) growth in an ex vivo model of posterior capsule opacification (PCO).

MATERIALS

LEC growth was evaluated for 14 days in canine lens capsules (LCs) that had been exposed to media containing 20 μM CXB for 1-5 days. After the incubation of hydrophilic and hydrophobic IOLs in CXB solution, the determination of the in vitro release of CXB from the IOLs was performed for up to 28 days. The incubated and nonincubated IOLs were evaluated in the ex vivo model of PCO, and the rate of LEC growth was evaluated over 28 days.

RESULTS

The treatment of LCs with 20 μM CXB for 4 and 5 days completely inhibited LEC growth. LEC repopulation did not occur after the removal of CXB. IOLs incubated in CXB for 24 h resulted in a sustained release of CXB in vitro at levels theoretically sufficient to inhibit PCO. LCs in the ex vivo model of PCO treated with acrylic IOLs incubated in CXB had significantly suppressed LEC ingrowth compared with untreated and IOL-only LCs.

CONCLUSIONS

A 4-day treatment of LCs with a concentration of 20 μM CXB may effectively prevent PCO. IOLs incubated in CXB for 24 h resulted in a sustained release of CXB in vitro at levels sufficient to inhibit LEC growth in the ex vivo model of PCO. Further studies are needed to determine whether CXB-incubated IOLs can effectively prevent the development of PCO in vivo.

摘要

目的

确定塞来昔布(CXB)能否从孵育的人工晶状体(IOL)中充分释放出来,以在后部囊膜混浊(PCO)的体外模型中抑制晶状体上皮细胞(LEC)的生长。

材料

将犬晶状体囊(LC)暴露于含有 20μM CXB 的培养基中 1-5 天,评估 LEC 生长 14 天。在 CXB 溶液中孵育亲水和疏水 IOL 后,对 IOL 中 CXB 的体外释放进行了长达 28 天的测定。评估孵育和未孵育的 IOL 在 PCO 的体外模型中的作用,并在 28 天内评估 LEC 生长率。

结果

用 20μM CXB 处理 LCs 4 和 5 天可完全抑制 LEC 的生长。去除 CXB 后,LEC 不会重新定植。在 CXB 中孵育 24 小时的 IOL 会导致体外持续释放 CXB,理论上足以抑制 PCO。与未处理和仅 IOL 的 LCs 相比,在 PCO 的体外模型中用孵育的 CXB 的丙烯酸 IOL 处理的 LCs 中,LEC 内生长受到明显抑制。

结论

用浓度为 20μM CXB 处理 LCs 4 天可能有效预防 PCO。在 CXB 中孵育 24 小时的 IOL 会导致体外持续释放 CXB,其水平足以抑制 PCO 的体外模型中的 LEC 生长。需要进一步的研究来确定 CXB 孵育的 IOL 是否能有效预防体内 PCO 的发展。

相似文献

1
Sustained-release celecoxib from incubated acrylic intraocular lenses suppresses lens epithelial cell growth in an ex vivo model of posterior capsule opacity.孵育后的丙烯酸人工晶状体中缓释塞来昔布抑制后发性白内障模型中外生性后囊混浊中晶状体上皮细胞的生长。
J Ocul Pharmacol Ther. 2012 Aug;28(4):359-68. doi: 10.1089/jop.2011.0196. Epub 2012 Feb 28.
2
Selenium functionalized intraocular lenses inhibit posterior capsule opacification in an ex vivo canine lens capsular bag assay.硒功能化人工晶状体抑制犬晶状体后囊袋模型体外后囊混浊。
Exp Eye Res. 2009 Nov;89(5):728-34. doi: 10.1016/j.exer.2009.06.016. Epub 2009 Jul 5.
3
Anti-Adhesive And Antiproliferative Synergistic Surface Modification Of Intraocular Lens For Reduced Posterior Capsular Opacification.用于减少后发性白内障的眼内透镜的抗粘连和抗增殖协同表面改性。
Int J Nanomedicine. 2019 Nov 19;14:9047-9061. doi: 10.2147/IJN.S215802. eCollection 2019.
4
A 3D in vitro model for assessing the influence of intraocular lens: Posterior lens capsule interactions on lens epithelial cell responses.评估人工晶状体:后囊晶状体相互作用对晶状体上皮细胞反应影响的 3D 体外模型。
Exp Eye Res. 2024 Jul;244:109940. doi: 10.1016/j.exer.2024.109940. Epub 2024 May 22.
5
The effect of phosphorylated Akt inhibition on posterior capsule opacification in an ex vivo canine model.磷酸化Akt抑制对离体犬模型后囊膜混浊的影响。
Mol Vis. 2010 Oct 29;16:2202-14.
6
Prevention of posterior capsular opacification through cyclooxygenase-2 inhibition.通过抑制环氧化酶-2预防后囊膜混浊。
Mol Vis. 2007 Apr 30;13:677-91.
7
The effect of polymethylmethacrylate and acrysof intraocular lenses on the posterior capsule in patients with a large capsulorrhexis.聚甲基丙烯酸甲酯和丙烯酸酯人工晶状体对行囊袋连续环形撕囊患者后囊膜的影响。
Jpn J Ophthalmol. 2001 Jul-Aug;45(4):348-54. doi: 10.1016/s0021-5155(01)00332-x.
8
Effect of time and temperature-dependent changes of IOL material properties on IOL: Lens capsule interactions.时间和温度依赖性变化对人工晶状体材料特性与晶状体囊袋相互作用的影响。
Exp Eye Res. 2021 Oct;211:108726. doi: 10.1016/j.exer.2021.108726. Epub 2021 Aug 14.
9
Active oxygen processing for acrylic intraocular lenses to prevent posterior capsule opacification.用于丙烯酸人工晶状体的活性氧处理以预防后囊膜混浊。
J Cataract Refract Surg. 2006 Jun;32(6):1035-40. doi: 10.1016/j.jcrs.2006.02.042.
10
Uveal and capsular biocompatibility of hydrophilic acrylic, hydrophobic acrylic, and silicone intraocular lenses.亲水丙烯酸酯、疏水丙烯酸酯和硅酮人工晶状体的葡萄膜及囊膜生物相容性。
J Cataract Refract Surg. 2002 Jan;28(1):50-61. doi: 10.1016/s0886-3350(01)01122-1.

引用本文的文献

1
Controlled Delivery of Celecoxib-β-Cyclodextrin Complexes from the Nanostructured Titanium Dioxide Layers.从纳米结构二氧化钛层中可控释放塞来昔布-β-环糊精复合物
Pharmaceutics. 2023 Jul 1;15(7):1861. doi: 10.3390/pharmaceutics15071861.
2
Research Progress Concerning a Novel Intraocular Lens for the Prevention of Posterior Capsular Opacification.一种新型人工晶状体预防后囊膜混浊的研究进展
Pharmaceutics. 2022 Jun 25;14(7):1343. doi: 10.3390/pharmaceutics14071343.
3
Posterior Capsule Opacification: A Review of Experimental Studies.后囊膜混浊:实验研究综述
J Clin Med. 2021 Jun 27;10(13):2847. doi: 10.3390/jcm10132847.
4
Therapeutic Ophthalmic Lenses: A Review.治疗性眼科镜片:综述
Pharmaceutics. 2020 Dec 28;13(1):36. doi: 10.3390/pharmaceutics13010036.
5
Research Progress of Drug Prophylaxis for Lens Capsule Opacification after Cataract Surgery.白内障手术后晶状体后囊膜混浊药物预防的研究进展
J Ophthalmol. 2020 Jul 4;2020:2181685. doi: 10.1155/2020/2181685. eCollection 2020.
6
Effect of anterior capsule polish on visual function: A meta-analysis.前囊抛光对视觉功能的影响:一项荟萃分析。
PLoS One. 2019 Jan 8;14(1):e0210205. doi: 10.1371/journal.pone.0210205. eCollection 2019.
7
CTGF Contributes to the Development of Posterior Capsule Opacification: an and study.CTGF 有助于后囊膜混浊的发展:一项 研究。
Int J Biol Sci. 2018 Mar 11;14(4):437-448. doi: 10.7150/ijbs.23946. eCollection 2018.
8
Physicochemical and surface properties of acrylic intraocular lenses and their clinical significance.丙烯酸人工晶状体的物理化学和表面性质及其临床意义。
J Pharm Investig. 2017;47(5):453-460. doi: 10.1007/s40005-017-0323-y. Epub 2017 Mar 27.
9
Dual function of TGFβ in lens epithelial cell fate: implications for secondary cataract.转化生长因子β在晶状体上皮细胞命运中的双重作用:对继发性白内障的影响
Mol Biol Cell. 2017 Apr 1;28(7):907-921. doi: 10.1091/mbc.E16-12-0865. Epub 2017 Feb 16.
10
Growth factor restriction impedes progression of wound healing following cataract surgery: identification of VEGF as a putative therapeutic target.生长因子受限阻碍白内障手术后伤口愈合进程:确定血管内皮生长因子为潜在治疗靶点。
Sci Rep. 2016 Apr 14;6:24453. doi: 10.1038/srep24453.

本文引用的文献

1
Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.制备稳定无定形纳米粒增强难溶性塞来昔布溶出度和生物利用度的机制。
J Pharm Pharm Sci. 2010;13(4):589-606. doi: 10.18433/j3530j.
2
The effect of phosphorylated Akt inhibition on posterior capsule opacification in an ex vivo canine model.磷酸化Akt抑制对离体犬模型后囊膜混浊的影响。
Mol Vis. 2010 Oct 29;16:2202-14.
3
Effect of delivery of MMP inhibitors from PDMS as a model IOL material on PCO markers.聚二甲基硅氧烷(PDMS)模型人工晶状体材料中基质金属蛋白酶抑制剂的释放对后发性白内障标志物的影响。
Biomaterials. 2010 Mar;31(8):2399-407. doi: 10.1016/j.biomaterials.2009.11.108. Epub 2009 Dec 22.
4
Layer-by-Layer modification of poly (methyl methacrylate) intra ocular lens: drug delivery applications.聚甲基丙烯酸甲酯(PMMA)人工晶状体的层层修饰:药物输送应用。
Pharm Dev Technol. 2010 Jul-Aug;15(4):379-85. doi: 10.3109/10837450903262025.
5
Selenium functionalized intraocular lenses inhibit posterior capsule opacification in an ex vivo canine lens capsular bag assay.硒功能化人工晶状体抑制犬晶状体后囊袋模型体外后囊混浊。
Exp Eye Res. 2009 Nov;89(5):728-34. doi: 10.1016/j.exer.2009.06.016. Epub 2009 Jul 5.
6
Documentation of capsular opacification and incomplete cell migration barrier formation by ThinOptX IOL using Miyake-Apple view.
Cont Lens Anterior Eye. 2009 Aug;32(4):181-3. doi: 10.1016/j.clae.2009.04.001. Epub 2009 May 1.
7
Posterior capsular opacification: a problem reduced but not yet eradicated.后囊膜混浊:问题有所减轻但尚未根除。
Arch Ophthalmol. 2009 Apr;127(4):555-62. doi: 10.1001/archophthalmol.2009.3.
8
Pharmacological attempts to reduce posterior capsule opacification after cataract surgery--a review.
Clin Exp Ophthalmol. 2008 Dec;36(9):883-90. doi: 10.1111/j.1442-9071.2009.01921.x.
9
Randomized intraindividual comparison of posterior capsule opacification between a microincision intraocular lens and a conventional intraocular lens.微切口人工晶状体与传统人工晶状体后囊膜混浊的随机个体内比较
J Cataract Refract Surg. 2009 Feb;35(2):265-72. doi: 10.1016/j.jcrs.2008.10.048.
10
Intraocular lens as a drug delivery system for dexamethasone.眼内透镜作为地塞米松的药物传递系统。
Acta Ophthalmol. 2010 Mar;88(2):241-4. doi: 10.1111/j.1755-3768.2008.01419.x. Epub 2009 Jan 27.